Bausch Health Companies
(NYSE) BHC
Bausch Health Companies Financials at a Glance
Market Cap
$2.11B
Revenue (TTM)
$10.55B
Net Income (TTM)
$1.19B
EPS (TTM)
$-3.25
P/E Ratio
-1.74
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$5.53
Volume
112,243
Open
$5.65
Price
$5.53
Volume
112,243
Open
$5.65
Previous Close
$5.53
Daily Range
$5.52 - $5.83
52-Week Range
$4.41 - $8.69
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$5.53
Volume
112,243
Open
$5.65
Previous Close
$5.53
Daily Range
$5.52 - $5.83
52-Week Range
$4.41 - $8.69
BHC News
What Does Bag Holder Mean?
BHC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bausch Health Companies
Industry
Pharmaceuticals
Sector
Health CareEmployees
20,300
CEO
Thomas J. Appio
Website
www.bauschhealth.comHeadquarters
Laval, QC H7L 4A8, CA
BHC Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
23%
Net Income Margin
-11%
Return on Equity
0%
Return on Capital
12%
Return on Assets
-5%
Earnings Yield
-57.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.11B
Shares Outstanding
373.46M
Volume
112.24K
Avg. Volume
1.96M
Financials (TTM)
Gross Profit
$6.36B
Operating Income
$2.22B
EBITDA
$3.45B
Operating Cash Flow
$1.40B
Capital Expenditure
$397.00M
Free Cash Flow
$1.00B
Cash & ST Invst.
$1.32B
Total Debt
$21.21B
Bausch Health Companies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.49B
+10.5%
Gross Profit
$1.52B
+17.4%
Gross Margin
61.21%
N/A
Market Cap
$2.11B
N/A
Market Cap/Employee
$101.94K
N/A
Employees
20,700
N/A
Net Income
$1.40B
-2326.8%
EBITDA
$804.70M
+35.2%
Quarterly Fundamentals
Net Cash
$19.50B
+4.3%
Accounts Receivable
$2.19B
+5.7%
Inventory
$1.60B
-0.7%
Long Term Debt
$19.89B
-6.3%
Short Term Debt
$900.00M
+219.1%
Return on Assets
-4.86%
N/A
Return on Invested Capital
12.11%
N/A
Free Cash Flow
$83.00M
-4.6%
Operating Cash Flow
$230.00M
+9.0%